Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,415.12 -131.15 -0.90%
TOPIX 1,164.44 -9.37 -0.80%
HANG SENG 22,514.66 5.02 0.02%

Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results on Thursday, January 30, 2014



  Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results
  on Thursday, January 30, 2014

Business Wire

CHESHIRE, Conn. -- January 16, 2014

Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that the Company
will report its financial results for the fourth quarter and year ended
December 31, 2013 on Thursday, January 30, 2014 before the US financial
markets open. Following the release of the financial results, Alexion
management will conduct a conference call and audio web cast on Thursday,
January 30, 2014, at 10:00 a.m. Eastern Time (ET).

To participate in this conference call, dial 888-487-0361 (USA) or
719-325-2249 (International), passcode 9926357 shortly before 10:00 a.m. ET. A
replay of the call will be available from 1:00 p.m. ET through a limited time
thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820
(International), passcode 9926357. The audio web cast can be accessed on the
Investor page of www.alexionpharma.com.

[ALXN-G]

Contact:

Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Executive Director
Corporate Communications
or
(Media)
Alexion Pharmaceuticals, Inc.
Kim Diamond, 203-439-9600
Senior Director, Corporate
Communications
or
(Investors)
Rx Communications
Rhonda Chiger, 917-322-2569
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement